Compare Stocks: BJDX, NDRA, PAVM, and SONX

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BJDX Bluejay Diagnostics	$1.07 -7.0%	$2.40	$0.83 ▼ $16.68	$1.11M	0.89	7.45 million shs	700,280 shs
NDRA ENDRA Life Sciences	$4.57	$4.89	$2.96 ▼ $9.85	$5.84M	-0.05	24,397 shs	3,887 shs
PAVM PAVmed	$4.74 -4.0%	$5.27	$3.85 ▼ $28.44	$4.72M	0.54	11,014 shs	2,112 shs
SONX Sonendo	$1.00	$0.71	$0.02 ▼ $1.01	$4.78M	1.81	1,497 shs	2 shs

7 Stocks That Will Be Magnificent in 2026

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BJDX Bluejay Diagnostics	0.00%	+24.42%	-23.57%	-39.38%	-81.80%
NDRA ENDRA Life Sciences	0.00%	-3.08%	-16.76%	-7.68%	-11.95%
PAVM PAVmed	0.00%	-4.24%	-14.59%	-33.80%	-65.96%
SONX Sonendo	0.00%	-0.99%	+66.67%	+25.00%	+4,445.45%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BJDX Bluejay Diagnostics	$1.07 -7.0%	$2.40	$0.83 ▼ $16.68	$1.11M	0.89	7.45 million shs	700,280 shs
NDRA ENDRA Life Sciences	$4.57	$4.89	$2.96 ▼ $9.85	$5.84M	-0.05	24,397 shs	3,887 shs
PAVM PAVmed	$4.74 -4.0%	$5.27	$3.85 ▼ $28.44	$4.72M	0.54	11,014 shs	2,112 shs
SONX Sonendo	$1.00	$0.71	$0.02 ▼ $1.01	$4.78M	1.81	1,497 shs	2 shs

7 Stocks That Will Be Magnificent in 2026

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BJDX Bluejay Diagnostics	0.00%	+24.42%	-23.57%	-39.38%	-81.80%
NDRA ENDRA Life Sciences	0.00%	-3.08%	-16.76%	-7.68%	-11.95%
PAVM PAVmed	0.00%	-4.24%	-14.59%	-33.80%	-65.96%
SONX Sonendo	0.00%	-0.99%	+66.67%	+25.00%	+4,445.45%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BJDX Bluejay Diagnostics	1.00	Sell	N/A	N/A
NDRA ENDRA Life Sciences	2.00	Hold	$25.00	447.05% Upside
PAVM PAVmed	2.00	Hold	$56.00	1,081.43% Upside
SONX Sonendo	0.00	N/A	N/A	N/A

Current Analyst Ratings Breakdown

Latest BJDX, NDRA, PAVM, and SONX Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/31/2026	NDRA ENDRA Life Sciences	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
7/17/2026	NDRA ENDRA Life Sciences	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
7/17/2026	PAVM PAVmed	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D)
6/24/2026	BJDX Bluejay Diagnostics	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
6/8/2026	PAVM PAVmed	Ascendiant Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Buy	$65.00 ➝ $56.00
6/1/2026	NDRA ENDRA Life Sciences	Ascendiant Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Buy	$27.00 ➝ $25.00

(Data available from 8/9/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BJDX Bluejay Diagnostics	N/A	N/A	N/A	N/A	$8.43 per share	N/A
NDRA ENDRA Life Sciences	N/A	N/A	N/A	N/A	$1.92 per share	N/A
PAVM PAVmed	$85K	55.54	N/A	N/A	($2.42) per share	-1.96
SONX Sonendo	$44.40M	0.11	N/A	N/A	$89.42 per share	0.01

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BJDX Bluejay Diagnostics	-$6.85M	-$11.63	N/A	N/A	N/A	N/A	-144.27%	-115.00%	8/19/2026 (Estimated)
NDRA ENDRA Life Sciences	-$7.03M	-$8.15	N/A	N/A	N/A	N/A	-433.64%	-204.58%	8/13/2026 (Estimated)
PAVM PAVmed	$400K	-$37.40	N/A	N/A	N/A	-21,914.12%	-146.19%	-18.39%	8/14/2026 (Estimated)
SONX Sonendo	-$60.92M	-$71.12	N/A	N/A	N/A	-92.74%	-184.01%	-68.60%	8/12/2026 (Estimated)

Latest BJDX, NDRA, PAVM, and SONX Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/14/2026	Q2 2026	PAVM PAVmed	-$0.63	N/A	N/A	N/A	$0.05 million	N/A
8/13/2026	Q2 2026	NDRA ENDRA Life Sciences	-$0.84	N/A	N/A	N/A	$0.10 million	N/A
5/15/2026	Q1 2026	NDRA ENDRA Life Sciences	-$1.23	-$1.09	+$0.14	-$1.09	N/A	N/A
5/14/2026	Q1 2026	PAVM PAVmed	-$0.69	-$1.17	-$0.48	-$4.42	$0.07 million	$0.02 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
BJDX Bluejay Diagnostics	N/A	N/A	N/A	N/A	N/A
NDRA ENDRA Life Sciences	N/A	N/A	N/A	N/A	N/A
PAVM PAVmed	N/A	N/A	N/A	N/A	N/A
SONX Sonendo	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BJDX Bluejay Diagnostics	N/A	2.81	2.81
NDRA ENDRA Life Sciences	N/A	0.64	0.64
PAVM PAVmed	0.70	2.02	2.02
SONX Sonendo	0.55	1.82	1.22

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BJDX Bluejay Diagnostics	18.47%
NDRA ENDRA Life Sciences	1.19%
PAVM PAVmed	19.93%
SONX Sonendo	28.68%

Insider Ownership

Company	Insider Ownership
BJDX Bluejay Diagnostics	6.10%
NDRA ENDRA Life Sciences	10.00%
PAVM PAVmed	13.40%
SONX Sonendo	7.90%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BJDX Bluejay Diagnostics	9	1.03 million	972,000	Not Optionable
NDRA ENDRA Life Sciences	20	1.27 million	1.14 million	Not Optionable
PAVM PAVmed	90	996,000	863,000	No Data
SONX Sonendo	250	4.78 million	393,000	Not Optionable

BJDX, NDRA, PAVM, and SONX Headlines

Recent News About These Companies

Sonendo, Inc. to Report Third Quarter 2024 Financial Results on November 12, 2024

June 26, 2026 | businesswire.com

Sonendo Stock Price, Quotes and Forecasts | OTC:SONX | Benzinga

April 8, 2026 | benzinga.com

Sonendo, Inc. on Path to Breakeven in the Second Half of 2026

March 16, 2026 | businesswire.com

Sonendo Strengthens Leadership Team With Promotion of John McGaugh to ...

August 22, 2025 | businesswire.com

Sonendo names John McGaugh COO

August 20, 2025 | msn.com

Sonendo Strengthens Leadership Team With Promotion of John McGaugh to Chief Operating Officer

August 20, 2025 | businesswire.com

Sonendo, Inc. Reports Second Quarter 2025 Financial Results and Reaffirms Financial Guidance

August 13, 2025 | businesswire.com

Sonendo, Inc. Reports First Quarter 2025 Financial Results and Issues Financial Guidance

June 4, 2025 | businesswire.com

Sonendo Inc. Reports Fourth Quarter and Full Year 2024 Financial Results

March 26, 2025 | businesswire.com

Sonendo, Inc. to Release Third Quarter 2024 Financial Results and Postpone Conference Call on November 12, 2024

November 11, 2024 | businesswire.com

Sonendo, Inc. (SONX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

November 5, 2024 | zacks.com

Sonendo Launches ProControlTM for the GentleWave® G4 System

October 23, 2024 | businesswire.com

Sonendo, Inc. Announces Preliminary Third Quarter 2024 Financial Results

October 10, 2024 | businesswire.com

BIOLASE files for Chapter 11, plans asset sale to Sonendo

October 3, 2024 | investing.com

Here's Why Sonendo (SONX) Is a Great 'Buy the Bottom' Stock Now

August 27, 2024 | zacks.com

Sonendo Inc.

August 17, 2024 | marketwatch.com

Sonendo, Inc. (SONX) Q2 2024 Earnings Call Transcript

August 10, 2024 | seekingalpha.com

Sonendo, Inc. (SONX) Reports Q2 Loss, Tops Revenue Estimates

August 7, 2024 | zacks.com

Sonendo, Inc. Reports Second Quarter 2024 Financial Results and Raises Full Year Revenue Guidance

August 7, 2024 | finance.yahoo.com

Here's what Wall Street expects from Sonendo's earnings report

August 7, 2024 | markets.businessinsider.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

BJDX, NDRA, PAVM, and SONX Company Descriptions

Bluejay Diagnostics NASDAQ:BJDX

$1.07 -0.08 (-6.96%)

Closing price 08/7/2026 04:00 PM Eastern

Extended Trading

$1.06 -0.02 (-1.40%)

As of 08/7/2026 07:59 PM Eastern

Bluejay Diagnostics, Inc., a medical diagnostic company, develops rapid test for the monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components. The company also offers ALLEREYE diagnostic test, a point-of-care device for the diagnosis of allergic conjunctivitis. In addition, it develops IL-6 for the monitoring of disease progression in critical care; as well as hsTNT/I and NT-proBNP for the monitoring of patients acuity with chest pain. The company was incorporated in 2015 and is headquartered in Acton, Massachusetts.

ENDRA Life Sciences NASDAQ:NDRA

$4.57 0.00 (0.00%)

Closing price 08/7/2026 03:58 PM Eastern

Extended Trading

$4.57 0.00 (0.00%)

As of 08/7/2026 07:34 PM Eastern

ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is developing thermo-acoustic enhanced ultrasound technology that uses radio frequency pulses to generate ultrasonic waves in tissue to create high-contrast images for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion. It has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.

PAVmed NASDAQ:PAVM

$4.74 -0.20 (-4.05%)

Closing price 08/7/2026 04:00 PM Eastern

Extended Trading

$4.88 +0.14 (+2.85%)

As of 08/7/2026 07:34 PM Eastern

PAVmed Inc. focuses on acquiring, developing, and commercializing novel products that target unmet needs in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; EsoCheck Esophageal Cell Collection Device, which consists of diagnostic test that serves as a testing tool for preventing esophageal adenocarcinoma deaths, through early detection of esophageal precancer in at-risk gastroesophageal reflux disease, including chronic heartburn and acid reflux or simply reflux in patients; and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay performed on surface esophageal cells collected with EsoCheck. Its product pipeline also comprises EsoCure EsoCure Esophageal Ablation Device for treating dysplastic BE; PortIO, an implantable intraosseous vascular access device; and Veris cancer care platform. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is headquartered in New York, New York.

Sonendo NYSE:SONX

$1.00 0.00 (0.00%)

As of 08/7/2026

Sonendo, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes devices for root canal therapy in the United States and Canada. It provides GentleWave, a tooth decay treatment, a technology platform designed for cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The company also offers SoundSeal, a material used to build and create a sealing platform on the top of the crown; and Sonendo-branded liquid solution of ethylenediaminetetraacetic acid EDTA that is used to help debride and disinfect the root canal system. In addition, it provides The Digital Office, a practice management software to enable an integrated digital office for dental practitioners. The company was formerly known as Dentatek Corporation and changed its name to Sonendo, Inc. in March 2011. The company was incorporated in 2006 and is headquartered in Laguna Hills, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest BJDX, NDRA, PAVM, and SONX Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest BJDX, NDRA, PAVM, and SONX Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

BJDX, NDRA, PAVM, and SONX Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

BJDX, NDRA, PAVM, and SONX Company Descriptions

Bluejay Diagnostics NASDAQ:BJDX

ENDRA Life Sciences NASDAQ:NDRA

PAVmed NASDAQ:PAVM

Sonendo NYSE:SONX

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest BJDX, NDRA, PAVM, and SONX Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest BJDX, NDRA, PAVM, and SONX Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

BJDX, NDRA, PAVM, and SONX Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

BJDX, NDRA, PAVM, and SONX Company Descriptions

Bluejay Diagnostics NASDAQ:BJDX

ENDRA Life Sciences NASDAQ:NDRA

PAVmed NASDAQ:PAVM

Sonendo NYSE:SONX

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools